NANOBIOTIX (NANO.PA) Stock Earnings & Estimates
Europe - Euronext Paris - EPA:NANO - FR0011341205 - Common Stock
18.24 EUR
-0.76 (-4%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 30.058M | -11.609M -138.62% | 28.611M 346.46% | 70.165M 145.24% | 43.191M -38.44% | 73.758M 70.77% | 57.877M -21.53% | 124.83M 115.68% | 274.96M 120.27% | 321.09M 16.78% | |
| EBITDA YoY % growth | -45.202M 11.40% | -24.78M 45.18% | -67.21M -171.23% | -19.992M 70.25% | -6.146M 69.26% | 18.462M 400.41% | -41.605M -325.35% | -45.869M -10.25% | 171.76M 474.46% | 74.011M -56.91% | 112.08M 51.44% | |
| EBIT YoY % growth | -46.702M 11.18% | -26.29M 43.71% | -68.83M -161.81% | -21.165M 69.25% | 5.956M 128.14% | 11.119M 86.69% | 9.689M -12.86% | -5.533M -157.11% | 60.833M 1,199.41% | 152.04M 149.93% | 184.17M 21.13% | |
| Operating Margin | N/A | -87.46% | 592.90% | -73.98% | 8.49% | 25.74% | 13.14% | -9.56% | 48.73% | 55.30% | 57.36% | |
| EPS YoY % growth | N/A -5.70% | -1.08 24.32% | -1.44 -33.33% | -0.63 55.91% | -0.82 -29.72% | -0.08 90.40% | -0.26 -228.00% | -0.28 -7.87% | 1.70 707.22% | 2.28 34.13% | 2.76 20.98% |
All data in EUR
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 0.08 107.81% | -0.14 -29.82% | 1.01 1,220.00% |
| Revenue Q2Q % growth | 37.381M 326.83% | 24.378M -8.48% | 94.86M 153.77% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | 9.103M 120.18% | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.11 76.09% | -0.32 | 0.21 | 65.21% |
| Q4 2024 Q2Q % growth | -0.98 -250.00% | -0.55 | -0.43 | -79.59% |
| Q2 2024 Q2Q % growth | -0.46 42.50% | -0.21 | -0.25 | -119.99% |
| Q4 2023 Q2Q % growth | -0.28 | 0.10 | -0.38 | -374.51% |
| Q2 2023 Q2Q % growth | -0.80 -5.26% | -0.73 | -0.07 | -8.93% |
| Q2 2022 Q2Q % growth | -0.76 13.64% | -0.71 | -0.05 | -6.44% |
| Q4 2021 Q2Q % growth | -0.47 4.08% | -0.71 | 0.24 | 34.17% |
| Q2 2021 Q2Q % growth | -0.88 3.30% | -0.66 | -0.22 | -32.73% |
| Q4 2020 Q2Q % growth | -0.49 | -0.78 | 0.29 | 36.79% |
| Q2 2020 Q2Q % growth | -0.91 | -1.12 | 0.21 | 18.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 26.638M 186.77% | 19.992M | 6.646M | 33.24% |
| Q4 2024 Q2Q % growth | -16.48M -150.07% | 11.874M | -28.354M | -238.79% |
| Q2 2024 Q2Q % growth | 9.289M 182.08% | 23.97M | -14.681M | -61.25% |
| Q4 2023 Q2Q % growth | 32.914M | 33.66M | -746K | -2.22% |
| Q2 2023 Q2Q % growth | 3.293M | 2.866M | 427K | 14.90% |
| Q2 2022 Q2Q % growth | -100.00% | 1.02M | -1.02M | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 1.02M | -1.02M | -100.00% |
| Q2 2021 Q2Q % growth | 10K -75.00% | 1.071M | -1.061M | -99.07% |
| Q4 2020 Q2Q % growth | 13K | 2.04M | -2.027M | -99.36% |
| Q2 2020 Q2Q % growth | 40K | 2.04M | -2M | -98.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | -19.25% | 15.02% |
| Revenue | N/A | N/A | -14.12% | -27.25% |